While neurotrophic keratitis remains our primary focus, early research shows the potential for our intracellular siRNA platform to extend into nerve repair, wound healing, and other areas where natural regeneration is limited.
Microtubules and FL2 plays a critical role in regulating cell motility across multiple tissue types. By temporarily silencing FL2, our platform restores the natural ability of cells to migrate, rebuild structure, and regenerate nerves. This gives our siRNA technology broad relevance across ocular, neural, and dermal therapeutic landscapes.
We partner with researchers, clinicians, and organizations committed to advancing pro-regenerative therapies across ophthalmology, nerve repair, and wound healing.